The outlook of companies tied to Viagra's past presents a complex investment picture . While the initial surge generated substantial gains, generic alternatives have significantly diminished sales . Investing in connected pharmaceutical companies now requires a careful assessment of intellectual property protection , evolving medical changes, and t